Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
SBIO
78
HOLDINGS
16%
ALSO IN IBRN
IBRN
57
HOLDINGS
29%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 3.2% | 4.1% | 3.2% |
 |
ACADIA PHARMACEUTICALS INC | 2.7% | 3.5% | 2.7% |
|
EDGEWISE THERAPEUTICS, INC. | 2.1% | 3.0% | 2.1% |
|
DENALI THERAPEUTICS INC. | 2.0% | 3.6% | 2.0% |
|
DIANTHUS THERAPEUTICS INC | 1.5% | 3.0% | 1.5% |
SBIO Overweight Relative to IBRN
|
KYMERA THERAPEUTICS, INC. | 4.7% |
|
CELCUITY INC. | 3.3% |
|
MIRUM PHARMACEUTICALS, INC. | 3.1% |
|
CG ONCOLOGY, INC. | 3.1% |
|
AMICUS THERAPEUTICS INC | 2.9% |
|
CRINETICS PHARMACEUTICALS INC | 2.5% |
|
APOGEE THERAPEUTICS, INC. | 2.5% |
|
VIKING THERAPEUTICS, INC. | 2.5% |
|
SPYRE THERAPEUTICS INC | 2.2% |
|
TARSUS PHARMACEUTICALS, INC. | 2.1% |
SBIO Underweight Relative to IBRN
|
AXSOME THERAPEUTICS, INC. | -4.5% |
|
SCHOLAR ROCK HOLDING CORP. | -4.4% |
|
BIOGEN IDEC INC | -4.3% |
|
SUPERNUS PHARMACEUTICALS INC | -4.1% |
|
CATALYST PHARMACEUTICAL PART | -3.7% |
|
NEUROCRINE BIOSCIENCES INC | -3.5% |
 |
ARGENX SE ADR | -3.4% |
|
PTC THERAPEUTICS INC | -3.4% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -2.6% |
|
DYNE THERAPEUTICS INC | -2.2% |